| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |